PANews reported on June 11 that according to Globenewswire, the listed biopharmaceutical company Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) announced that the company has increased its holdings of Bitcoin and other cryptocurrencies with the approval of the board of directors, bringing the total value of its BTC and other cryptocurrencies to $5 million. Compared with the $4.5 million position disclosed on May 19, it has increased by $500,000. The company emphasized that it will continue to allow financing and other transactions in cryptocurrencies in the future.